In addition, three hours prior to the experiment, the microcarrier-6 was further modified with SDF-1α and VEGF to accelerate blood vessel formation and provide a blood supply for rapid tumor growth, which surpassed the antitumor immune effect of the mice. The gene discussed is VEGFA; the disease is neoplasm.